Nanogen Licenses Molecular Technology to Quest for In Vitro Testing
Nanogen Inc, announced today that it has signed an end user license agreement (EULA) with Quest Diagnostics for use of the Companys proprietary MGB Probe technology in human in vitro diagnostic testing.
Read More